"The voice for cancer physicians and their patients in Massachusetts."

FDA recognizes Memorial Sloan-Kettering database of molecular tumor marker information

07 Oct 2021 5:30 PM | Katy Monaco (Administrator)
The Food and Drug Administration granted recognition to a partial listing of the Memorial Sloan Kettering Cancer Center’s Oncology Knowledge Base (OncoKB) as the first tumor mutation database to be included in the Public Human Genetic Variant Databases.  October 7, 2021.  More Information.

© Copyright.  All rights reserved. 

Massachusetts Society of Clinical Oncologists

P.O. Box 549154, Waltham, MA, 02454
Tel: 781.434.7329 | Fax: 781.464.4896 | email: msco@mms.org

Powered by Wild Apricot Membership Software